Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2005
05/18/2005CN1202128C Immunogenicity of modified protein
05/18/2005CN1202127C Immunostimulant bacterial membrane tractions in cancer treatment
05/18/2005CN1202125C Peptide immunogen, vaccine made thereof for curing allergic reaction and its preparation method
05/18/2005CN1201819C Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
05/18/2005CN1201818C Vaccine
05/18/2005CN1201815C Stabilizer for recombinant alpha-interferon liquid
05/17/2005US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
05/17/2005US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders
05/17/2005US6894154 Medical equipment comprising nucleic acid codes for wild-type human kinase interacting stathmin (hKIS) phosphoproteins, used for drug delivery; antiproliferative agents
05/17/2005US6894153 Gene Any-RF; dormancy regulatory substance, process for producing the same and cell regulator for vital cells
05/17/2005US6894150 Blood substitute for human/mammal transfusions in vivo; comprises lysis/centrifugation of erythrocytes; cross-linking
05/17/2005US6894147 Intermediate conductance calcium-activated potassium channels (IK1)
05/17/2005US6894146 Anticarcinogenic drugs for prevention of disease; fusion proteins; genetic engineering
05/17/2005US6894031 Polynucleotides; in situ injection
05/17/2005US6894028 Use of KPV tripeptide for dermatological disorders
05/17/2005US6894023 Salt formation, heating, isolation
05/17/2005US6894022 Growth factor modified protein matrices for tissue engineering
05/17/2005US6893872 Pesticidal toxins
05/17/2005US6893870 Pancreas-derived plasminogen activator inhibitor
05/17/2005US6893869 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering
05/17/2005US6893865 Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles
05/17/2005US6893858 Human kcnq5 potassium channel, methods and compositions thereof
05/17/2005US6893856 Generating preferential compounds in sample; obtain sample, perform solid phase extraction, elute, recover compounds
05/17/2005US6893853 Nucleic acid fragments encoding chromatin associated proteins in plants and seeds; construction of a chimeric gene encoding all or a portion of the chromatin associated protein in sense or antisense orientation
05/17/2005US6893845 Surface expression libraries of heteromeric receptors
05/17/2005US6893844 DNA encoding a new human hepatoma derived growth factor and producing method thereof
05/17/2005US6893843 Nucleic acids
05/17/2005US6893842 T-type calcium channel variants; compositions thereof; and uses
05/17/2005US6893841 Nucleotide sequences coding polypeptide for use in tool in treatment of defects in protein transport
05/17/2005US6893838 DADD, death activator death domain protein
05/17/2005US6893818 Gene upregulated in cancers of the prostate
05/17/2005US6893645 Process to make a sustained release formulation
05/17/2005US6893640 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
05/17/2005US6893638 Methods for treating b cell lymphoma using CD80-specific antibodies
05/17/2005US6893637 Method of treating fibrosis
05/17/2005CA2486752A1 Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure
05/17/2005CA2375673C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions
05/17/2005CA2248144C Horse endothelin-b receptor gene and gene products
05/17/2005CA2234409C Transferrin receptor protein of moraxella
05/17/2005CA2202390C Keratinocyte growth factor analogs
05/17/2005CA2182393C Dna mutagenesis by random fragmentation and reassembly
05/17/2005CA2132374C Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
05/12/2005WO2005043158A1 Recombined cell system for deorphanizing g protein-coupled receptors
05/12/2005WO2005042782A1 Methods for reducing seizure-induced neuronal damage
05/12/2005WO2005042758A1 Method for flocculation of a fermentation broth comprising a fungus
05/12/2005WO2005042749A1 Expression system for the b subunit of cholera toxin
05/12/2005WO2005042746A1 Bacterial virulence factors and uses thereof
05/12/2005WO2005042745A1 Meg1 endosperm-specific promoters and genes
05/12/2005WO2005042744A1 A recombinant protein with cancer suppression action, its encoding gene and use
05/12/2005WO2005042742A1 Monkey npy y4 recepotr and method of evaluating compound
05/12/2005WO2005042740A1 Method of enhancing hematopoiesis-supporting ability of immortalized human bone marrow stroma cell by transferring indian hedgehog gene
05/12/2005WO2005042738A1 Dose-dependent promoter originating in humans
05/12/2005WO2005042735A1 Carbohydrate-binding modules of a new family
05/12/2005WO2005042733A1 Hbv variants detection and application
05/12/2005WO2005042732A2 STABLE CELL LINES EXPRESSING HERG1a AND HERG1b
05/12/2005WO2005042725A2 Liver cancer biomarkers
05/12/2005WO2005042717A2 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
05/12/2005WO2005042711A2 Pain-associated gene pnpg1
05/12/2005WO2005042699A2 Modified polypeptides with therapeutic activity and methods of use
05/12/2005WO2005042698A2 T cell epitopes useful in a hepatitis c virus vaccine and as diagnostic tools and methods for identifying same
05/12/2005WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same
05/12/2005WO2005042693A2 Hla-e chimeric molecule
05/12/2005WO2005042577A1 Ddr2 protein with activated kinase activity and preparation method thereof
05/12/2005WO2005042576A1 Clq RELATED PROTEIN
05/12/2005WO2005042575A2 Method for down-regulation of vegf
05/12/2005WO2005042574A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
05/12/2005WO2005042573A1 Modulation of the interaction of muc1 with muc1 ligands
05/12/2005WO2005042572A1 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
05/12/2005WO2005042571A1 Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulations
05/12/2005WO2005042570A1 Hcv ns3-ns4a protease resistance mutants
05/12/2005WO2005042569A1 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
05/12/2005WO2005042566A2 Antiangiogenicpeptides for treating or preventing endometriosis
05/12/2005WO2005042565A2 Cyclin groove inhibitors
05/12/2005WO2005042564A1 Flagellin fusion proteins as adjuvants or vaccines and methods of use
05/12/2005WO2005042561A2 Neural regeneration peptides and methods of use
05/12/2005WO2005042560A2 Non-viral delivery of compounds to mitochondria
05/12/2005WO2005042559A2 Capture and release based isotope tagged peptides and methods for using the same
05/12/2005WO2005042024A1 Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
05/12/2005WO2005042016A2 Stabilised compositions
05/12/2005WO2005042008A1 Agent against malignant neuroglia and agent against malignant neuroglia for animals
05/12/2005WO2005042006A2 Use of ephrins and related molecules to regulate cellular proliferation
05/12/2005WO2005042005A1 Amino acid composition with increased blood brain barrier permeability
05/12/2005WO2005041898A2 Blood substitutes
05/12/2005WO2005041890A2 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
05/12/2005WO2005041882A2 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
05/12/2005WO2005041868A2 Epidermal growth factor receptor modulation protects normal tissue
05/12/2005WO2005041758A2 Novel cell-based assays employing voltage and calcium dyes
05/12/2005WO2005026207A3 Adipocyte complement related protein zacrp12
05/12/2005WO2005026192A3 Hpv cd8+ t-cell epitopes
05/12/2005WO2005021777A3 Uses of spatial configuration to modulate protein function
05/12/2005WO2005021724A3 Gp115: methods and compositions for treating cancer
05/12/2005WO2005019432A3 A novel gene and protein associated with angiogenesis and endothelial apoptosis
05/12/2005WO2005019269A3 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
05/12/2005WO2005019249A8 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
05/12/2005WO2005012530A3 Antagonists and agonists of ldcam and methods of use
05/12/2005WO2005010152A3 Human mast cell-expressed membrane protein
05/12/2005WO2005005596A3 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof
05/12/2005WO2004111240A3 Sequence for the bacillomycin d synthesis in bacillus amyloliquefaciens fzb42
05/12/2005WO2004111089A3 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
05/12/2005WO2004109291A3 Method for diagnosis and therapy of hazelnut-induced systemic reaction
1 ... 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 ... 2916